Tilray and Aurora among select few to provide medicinal cannabis products for French trial

Growth op

Two Canadian cannabis companies are among a mere handful of businesses to be providing cannabis-related products for a medical marijuana trial in France involving 3,000 patients. After being judged on product, manufacturing and supply criteria, both Tilray and Aurora Cannabis made the cut. Like the other companies involved in the pilot project, all medicine will be supplied free of charge to both the French government and the participating patients. The hope is to shed light on how effective cannabis can be in treating conditions such as neuropathic pain, certain drug-resistant types of epilepsy, spasticity associated with multiple sclerosis and the side effects of chemotherapy. Weed withdrawal: More than half of people using medical cannabis for pain experience withdrawal symptoms Study: Cannabis legalization leading to a decline in opioid prescriptions Canadian companies pushing the cannabis envelope To help brighten effectiveness, France’s National Agency for Medicines and Health Products Safety (ANSM) last week announced the final list of companies tasked with supplying the medicines. Calling Tilray’s inclusion “another milestone” as it expands operations in Europe, CEO Brendan Kennedy voiced pride “to be able to offer access to a variety of high-quality, pharmaceutical-grade medical cannabis products to the ANSM while supporting patients in need in France.” Company officials “fully appreciate the stakes of this experiment for French patients, and we are determined to contribute to its success actively,” Sascha Mielcarek, Tilray’s general manager for Europe, adds in the statement. All company products are Good Manufacturing Processes (GMP)-certified, will be sourced from Tilray’s GMP-certified facility in Portugal and will be supplied over the course of the trial, expected to run for 18 to 24 months. “Providing high-quality, medical cannabis dried flower to the French pilot program is the first and very important step towards providing better access and will support the destigmatization of medical…

Excerpt only …
Source : Tilray and Aurora among select few to provide medicinal cannabis products for French trial

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.